Boost engagement, build classroom community, and help students see themselves as storytellers through story-acting.

A research team from the University of Zurich and the University Children's Hospital Zurich has developed a new approach for treating children with malignant tumors of the nervous system.

Developed by Paris, France-based EssilorLuxottica and made for children as young as 6, the brand-new Stellest lenses slow the progression of myopia.

Chronic absenteeism remains high among California students. But some parents, especially those of kindergartners, don’t want ...

Kids who received oseltamivir during their flu-related hospitalization were 31% less likely to be admitted to the ICU ...

The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, ...

The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...

Watch as Gabe Fholer rings the bell to celebrate being cancer-free. Doctors say a breakthrough drug helped make it happen.